130 related articles for article (PubMed ID: 33331187)
1. Use of fluorescein sodium to obtain histological diagnosis of primary Central nervous system lymphoma ghost tumour despite disappearance on intraoperative magnetic resonance imaging: technical note and review of the literature.
Lim JX; Loh D; Tan L; Lee L
Br J Neurosurg; 2024 Apr; 38(2):244-248. PubMed ID: 33331187
[TBL] [Abstract][Full Text] [Related]
2. Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI.
Lin FH; Zhang XH; Zhang J; He ZQ; Duan H; Ke C; Sai K; Jiang XB; Al-Nahari F; Xi SY; Mou YG
J Neurooncol; 2018 Sep; 139(3):757-765. PubMed ID: 30117022
[TBL] [Abstract][Full Text] [Related]
3. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients.
Kiesel B; Millesi M; Woehrer A; Furtner J; Bavand A; Roetzer T; Mischkulnig M; Wolfsberger S; Preusser M; Knosp E; Widhalm G
Neurosurg Focus; 2018 Jun; 44(6):E7. PubMed ID: 29852770
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Demyelinating Lesions: True Sentinel Lesion or Immune-Mediated Response to Lymphoma?
Qiu T; Chanchotisatien A; Qin Z; Wu J; Chu S
World Neurosurg; 2021 Jan; 145():172-177. PubMed ID: 32949800
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative magnetic resonance-guided frameless stereotactic biopsies - initial clinical experience.
Czyż M; Tabakow P; Jarmundowicz W; Lechowicz-Głogowska B
Neurol Neurochir Pol; 2012; 46(2):157-60. PubMed ID: 22581597
[TBL] [Abstract][Full Text] [Related]
6. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
[TBL] [Abstract][Full Text] [Related]
7. Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation.
Yamaguchi S; Hirata K; Kaneko S; Kobayashi H; Shiga T; Kobayashi K; Onimaru R; Shirato H; Tamaki N; Terasaka S; Houkin K
Acta Neurochir (Wien); 2015 Feb; 157(2):187-94. PubMed ID: 25488176
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative imaging technology to maximise extent of resection for glioma.
Jenkinson MD; Barone DG; Bryant A; Vale L; Bulbeck H; Lawrie TA; Hart MG; Watts C
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012788. PubMed ID: 29355914
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic impact of preoperative corticosteroids in primary central nervous system lymphoma.
Bullis CL; Maldonado-Perez A; Bowden SG; Yaghi N; Munger D; Wood MD; Barajas RF; Ambady P; Neuwelt EA; Han SJ
J Clin Neurosci; 2020 Feb; 72():287-291. PubMed ID: 31648968
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review.
Norrington M; Rathi N; Jenkinson MD; Mills SJ
J Clin Neurosci; 2021 Jul; 89():381-388. PubMed ID: 34083111
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
[TBL] [Abstract][Full Text] [Related]
12. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
Wang P; Shi YH; Li JY; Zhang CZ
World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fluorescein sodium, 5-ALA, and intraoperative MRI for resection of high-grade gliomas: A systematic review and network meta-analysis.
Naik A; Smith EJ; Barreau A; Nyaeme M; Cramer SW; Najafali D; Krist DT; Arnold PM; Hassaneen W
J Clin Neurosci; 2022 Apr; 98():240-247. PubMed ID: 35219089
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches.
Hunt MA; Jahnke K; Murillo TP; Neuwelt EA
Neurosurg Focus; 2006 Nov; 21(5):E3. PubMed ID: 17134119
[TBL] [Abstract][Full Text] [Related]
15. ["Ghost and mimicry-tumor"--primary CNS lymphoma].
Heckmann JG; Druschky A; Kern PM; Romstöck J; Huk W; Neundörfer B
Nervenarzt; 2000 Apr; 71(4):305-10. PubMed ID: 10795099
[TBL] [Abstract][Full Text] [Related]
16. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
17. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma imitates multiple sclerosis.
DeAngelis LM
J Neurooncol; 1990 Oct; 9(2):177-81. PubMed ID: 2262803
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative visualisation of functional structures facilitates safe frameless stereotactic biopsy in the motor eloquent regions of the brain.
Zhang JS; Qu L; Wang Q; Jin W; Hou YZ; Sun GC; Li FY; Yu XG; Xu BN; Chen XL
Br J Neurosurg; 2018 Aug; 32(4):372-380. PubMed ID: 29260585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
